Windlas Biotech Buyback of ā¹47 crores was approved by the board of directors at the meeting held on April 17, 2026. Windlas Biotech Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ā¹5 each equity share at a price of ā¹1000 per Equity Share and for an aggregate amount not exceeding ā¹47 crores from the shareholders. Check out Windlas Biotech Buyback 2026 details below:
Windlas Biotech Buyback About us
Incorporated in 2001, Windlas Biotech is a well-established Indian Pharmaceutical and a leading Contract Development and Manufacturing Organisation (CDMO) company. This Dehradun-based company manufactures a wide range of pharmaceutical products in different dosage forms, including tablets, capsules, sachets, and liquids. In tablets, they use various technologies such as Enteric-coated, Sustained-release, Bilayer, and Capsules with pellet and powder combinations.
Moreover, very recently, the company also expanded its capabilities into injectables with advanced sterile solutions targeted to both Indian and international markets. Since 2021, the firm has increased its capsule/tablet capacity from 5 bn to 7+ bn to meet growing demand. Along with making medicines, the firm also engaged in trade, generics, and the institutional sectors.
Windlas Biotech Buyback History
- N/A
Windlas Biotech Buyback 2026 Dates
| Buyback Meeting Date: | April 17, 2026 |
| Buyback Announcement Date: | April 17, 2026 |
| Buyback Record Date: | April 24, 2026 |
| Last Date to Buy Shares: | 2026 |
| Buyback Open Date: | April 30, 2026 |
| Buyback Close Date: | May 7, 2026 |
| Finalization of Buyback Acceptance: | May 13, 2026 |
Windlas Biotech Buyback 2026 Offer Details
Windlas Biotech Buyback ofĀ 4,70,000 equity shares at a price of ā¹1000 per equity share. The buyback offers not to exceed ā¹47 crores of the total buyback offer size.
| Offer Amount: | ā¹47 Crores |
| Number of Shares: | 4,70,000 Equity Shares |
| Face Value: | ā¹5Ā per equity share |
| Buyback Price: | ā¹1000 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
Windlas Biotech Buyback 2026 Acceptance Ratio
The investor should buy around 200 shares at a current market price of ā¹852.50 (as of date). The calculation will be ā¹2,00,000 / ā¹1000 buyback price = 200 shares.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
| 33% | ā¹1,72,600 | 66 | ā¹9,042 |
| 50% | ā¹1,72,600 | 100 | ā¹13,700 |
| 75% | ā¹1,72,600 | 150 | ā¹20,550 |
| 100% | ā¹1,72,600 | 200 | ā¹27,400 |
Windlas Biotech Financial Report
| ā¹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ā¹523.05 | ā¹465.99 | ā¹42.64 |
| 2024 | ā¹644.42 | ā¹567.40 | ā¹58.14 |
| 2025 | ā¹777.52 | ā¹698.13 | ā¹60.65 |
How to Participate in Windlas Biotech Buyback 2026
The investors, who have Windlas Biotech Buyback shares in their Demat Account as of the Record Date, are eligible for the buyback scheme. Eligible Shareholders can participate in the Windlas Biotech Buyback 2026 scheme as per the opening form by selling their shares. The payment will be made as per the Windlas Biotech Buyback, with shares accepted by the company under the Windlas Biotech Buyback scheme.
Windlas Biotech Buyback 2026 Registrar
MUFG Intime India Pvt. Ltd.
Phone: 91-22-4918 6270
Email:
Website: https://in.mpms.mufg.com/Offer/Default.aspx
Windlas Biotech Buyback 2026 Lead Managers
- To be updated soon
Windlas Biotech Company Address
Windlas Biotech Limited
40/1,
Mohabewala Industrial Area,
Dehradun-248110,
Uttarakhand, India
Phone: 91-135-6608000
Email: grievance@windlasbiotech.com
Website: https://windlas.com/
